Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
STJ > SEC Filings for STJ > Form 8-K on 7-Jan-2009All Recent SEC Filings

Show all filings for ST JUDE MEDICAL INC | Request a Trial to NEW EDGAR Online Pro

Form 8-K for ST JUDE MEDICAL INC


7-Jan-2009

Change in Directors or Principal Officers, Financial Statements and Exhibits


Item 5.02 Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On December 31, 2008, St. Jude Medical, Inc. (the "Company") entered into change of control severance agreements (the "Severance Agreements") with its executive officers. The Severance Agreements supersede and replace the previous severance agreements between the Company and such executive officers and were modified primarily in order to bring the terms of the agreements into compliance with
Section 409A of the Internal Revenue Code of 1986, as amended.

The Severance Agreements provide for certain payments and other benefits if, following a Change in Control, the Company terminates the executive's employment without Cause or the executive terminates his or her employment for Good Reason. Such payments and benefits include: (1) a lump sum severance payment equal to 2.9 times the sum of the executive's annual salary, target bonus, annual perk package and certain other compensation paid to the executive during the 12 months prior to the termination; (2) three years of life, health, accident and disability insurance benefits substantially similar to those in effect at the time of termination; (3) payment of legal fees and expenses relating to the termination; and (4) a gross-up payment for certain excise taxes, if they are imposed on such payments or benefits, and for any tax imposed on such gross-up payment.

Under the Severance Agreements, "Change in Control" is defined to include a change in control of the type required to be disclosed under Securities and Exchange Commission proxy rules, acquisition by a person or group of 35% of the outstanding voting stock of the Company, a proxy fight or contested election which results in Continuing Directors (as defined in the Severance Agreements) not constituting a majority of the Company's Board of Directors, or another event that the majority of the Continuing Directors determines to be a change in control, and "Cause" is defined as a conviction for felony criminal conduct. "Good Reason" is defined to include a change in the executive's responsibility or status, a reduction in annual compensation or benefits, a mandatory relocation or the failure by the Company to obtain an assumption of the Company's obligations under the Severance Agreements by any successor to the Company. In addition, if the Change in Control arises from a transaction which is not authorized, recommended or approved by formal action taken by the Continuing Directors, the executive may voluntarily terminate his or her employment for any reason on the 180th day following the Change in Control, and such termination will be deemed "Good Reason" under the Severance Agreements.

The above summary of the Severance Agreements is qualified in its entirety by reference to the full text of the Severance Agreements, a form of which is attached as Exhibit 10.1 and incorporated herein by reference.




Item 9.01 Financial Statements and Exhibits.

(d) Exhibits:

10.1 Form of Severance Agreement between St. Jude Medical, Inc. and its executive officers.


  Add STJ to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for STJ - All Recent SEC Filings
Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial      Sign Up Now


Copyright © 2009 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.